Merck is suing the US government to stop drug price negotiations
NEW YORK (Reuters) – Merck & Co. (MRK.N) filed a lawsuit against the U.S. government on Tuesday seeking to block the Medicare drug price negotiation program included in the Inflation Reduction Act (IRA) that it says violates Title Five. The First Amendments to the United States Constitution. This is the first attempt by the drugmaker …
Merck is suing the US government to stop drug price negotiations Read More »